Compare EQH & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | SNN |
|---|---|---|
| Founded | 1859 | 1856 |
| Country | United States | United Kingdom |
| Employees | 8000 | 16988 |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 14.3B |
| IPO Year | N/A | N/A |
| Metric | EQH | SNN |
|---|---|---|
| Price | $43.80 | $29.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $56.82 | $36.25 |
| AVG Volume (30 Days) | ★ 4.0M | 1.1M |
| Earning Date | 05-04-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.60% | 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $43.13 | $8.58 |
| Revenue Next Year | $7.45 | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.20 | $29.08 |
| 52 Week High | $56.61 | $38.79 |
| Indicator | EQH | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 45.14 |
| Support Level | $42.30 | $29.10 |
| Resistance Level | $46.93 | $31.28 |
| Average True Range (ATR) | 1.15 | 0.46 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 51.02 | 26.54 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.